BUSINESS● LOWAug 3 · Aug 3, 2026, 8:04 PM
Vertex Pharmaceuticals Non-GAAP EPS of $4.73 misses by $0.02, revenue of $3.33B beats by $110M
Seeking Alpha Tech
Vertex Pharmaceuticals reported Non-GAAP EPS of $4.73, missing estimates by $0.02, while its revenue of $3.33B exceeded expectations by $110M. This financial report presents mixed results for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS23m agoIBM Q3 Preview: Can software and AI rebuild confidence after a rough Q2?Seeking Alpha TechBUSINESS24m agoJapan resumes imports of Ukrainian poultry after five-year restrictionsUkrinform [en]